neoplasm
• about 20% of mutants develop mammary tumors by the 25th week of age, and by the 30th week, tumor incidence increases to 83%
• high dose of flaxseed oil (with a an omega6:omega3 fatty acid ratio of about 1) results in some delay in the growth of mammary tumors, however low and mid doses with omega6:omega3 ratios of 7.7 and 3.1 enhance tumor development
• melatonin treatment delays the appearance of palpable tumors
• combination of both flaxseed oil and melatonin results in a slight delay of tumor development, similar that seen with melatonin only
|
integument
• about 20% of mutants develop mammary tumors by the 25th week of age, and by the 30th week, tumor incidence increases to 83%
• high dose of flaxseed oil (with a an omega6:omega3 fatty acid ratio of about 1) results in some delay in the growth of mammary tumors, however low and mid doses with omega6:omega3 ratios of 7.7 and 3.1 enhance tumor development
• melatonin treatment delays the appearance of palpable tumors
• combination of both flaxseed oil and melatonin results in a slight delay of tumor development, similar that seen with melatonin only
|
endocrine/exocrine glands
• about 20% of mutants develop mammary tumors by the 25th week of age, and by the 30th week, tumor incidence increases to 83%
• high dose of flaxseed oil (with a an omega6:omega3 fatty acid ratio of about 1) results in some delay in the growth of mammary tumors, however low and mid doses with omega6:omega3 ratios of 7.7 and 3.1 enhance tumor development
• melatonin treatment delays the appearance of palpable tumors
• combination of both flaxseed oil and melatonin results in a slight delay of tumor development, similar that seen with melatonin only
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
breast cancer | DOID:1612 |
OMIM:114480 |
J:67457 |